Built by people who have
run the process.
We are a small team of bioprocess operators and enterprise software engineers with around 150 years of collective experience across drug substance and drug product manufacturing, GMP facility design, and large-scale AI systems. Between us we have taken commercial molecules through development, transfer, qualification and supply, and written the reports at three in the morning.
That is why the platform is shaped the way it is. Every part of it exists because somebody on this team lost a week to the problem it solves.
Our mission
To give bioprocess organizations back the time they currently spend proving what they already know.
Faster development, cleaner transfers, shorter investigations and defensible filings, not by replacing the scientist, but by removing the assembly work that sits between them and the decision.
Four rules we do not bend.
These are engineering constraints in the codebase, not values on a wall.
The record comes before the model
An AI answer is only as good as the thing it is answering about. We built the system of record, molecules, runs, result tables, inventory, batch records, documents, before we let a model near it.
A claim without evidence is not an answer
Everything the platform asserts carries the tool result it came from. Where the evidence is not there, it says so. That single rule is what makes the output usable inside a GxP process.
Fail loud, never fall back
No fuzzy matching, no near-enough substitution, no silent default that makes a demo look good. When something is missing you are told, at the moment it matters.
The scientist decides
The AI assembles, computes and proposes. A named human confirms, and signs. We are not trying to remove judgment from this industry, we are trying to stop spending it on document retrieval.
The team.
Samir has extensive bioprocess experience, working at various large and small pharma and biotech companies, including Nutcracker Therapeutics, Allakos Inc., Enzene Biosciences, and Bristol Myers Squibb. He has expertise in drug substance and drug product manufacturing, GMP facility design, and supply chain operations. Samir has worked on various commercial molecules such as Yervoy®, Orencia®, Nulojix®, and Reblozyl®.
Samir was awarded a BE in Chemical Engineering from the National Institute of Technology, Karnataka, India, an MS in Biochemical Engineering from Drexel University, Philadelphia, PA, and an MBA in Finance and Marketing from the Stern School of Business at New York University, New York, NY.
BioProcess.AI was born from Samir‘s vision to revolutionize biotech manufacturing processes. His deep understanding of the industry and commitment to innovation have been instrumental in developing BioProcess.AI‘s cutting-edge solutions.
Hari brings over 25 years of experience in software development and technology leadership, with a proven track record of delivering innovative AI/ML-based SaaS solutions across multiple industries. He has held key roles at Oracle, GE Digital, and BlackBerry, where he led cross-functional teams and drove technological innovation and business growth.
Hari holds a Master‘s and Bachelor‘s degree in Computer Science from the University of Pune.
Renowned for his ability to take products from concept to multi-million dollar ARR, Hari Menon is a pivotal force behind BioProcess.AI‘s success.
Mandeep Bedi is a seasoned executive in the pharmaceuticals and biotechnology sectors, with expertise in commercial growth, strategic partnerships, and product management. He is currently the Chief Commercial Officer at Bioprocess Al, where he drives growth and enhances market presence. Since July 2024, Mandeep has also served as Vice President of Sales and Global Business Development at TECNIC.
Previously, he spent nearly a decade at Repligen Corporation, advancing from Commercial Project Manager to Director of Product Management and managing a $100M+ upstream franchise, where his leadership solidified Repligen’s status in upstream biomanufacturing.
Earlier, he was a Management Consultant in PwC’s Pharma and Lifesciences Advisory, guiding enterprises such as AbbVie and non-profits such as the Bill and Melinda Gates Foundation.
Mandeep’s extensive experience in bioprocessing, product and business development, and strategic planning enables him to make significant contributions to advancing technologies.
Join us.
This problem needs bioprocess scientists and serious software engineers in the same room, arguing. If that sounds good rather than exhausting, talk to us.
Open positions